课题基金 / 基金详情

Analysis of molecular signal transduction pathway between M-CSF and c-fms involved in uterine cervical cancer

Analysis of molecular signal transduction pathway between M-CSF and c-fms involved in uterine cervical cancer
M-CSF与c-fms参与宫颈癌的分子信号转导通路分析
批准号:
13671744
负责人:
SUZUKI Nao
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

SUZUKI Nao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human chorionic gonadotoropin (HCG) is a glycoprotein hormone normally produced by placenta during pregnancy. It is also well known that HCG is produced ectopicafly by many nontrophoblastic neoplasms including uterine cervical carcinoma. On the other hand, we have reported that macrophage colony-stimulating factor (M-CSF), and c-fms, a receptor tyrosine kinase for M-CSF play important functional roles in the differentiation of a human embryonal carcinoma cell line, NCR-G3 (G3) cells into trophoectoderm which produce HCG retinoic acid (RA) treatment. In this study, we investigated the relationship between ectopic production of HCG and signal transduction pathway of MCF and c-fms in uterine cervical carcinoma using uterine carcinoma cell lines (SKG-I, SKG-II, SKG-IIIa, SKG-IIIb) established in our laboratory. As a result, unfortunately we could not find out the mechanism of ectopic production of HCG in relation to the signal transduction of M-CSF and c-fms in uterine cervical carcinoma
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative Technological Development of Fertility Preservation Treatment Oriented to Improve Cancer Survivorship
The research that aims at the establishment of an efficient ovarian tissue cryopreservation and transplantation method - For the young female cancer patients
Basic research on the auto-transplantation of cryopresedved ovarian tissue - Aiming at the quality of life improvement of the young woman cancer patient.
  • 批准号:
    20591933
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2008
  • 负责人:
    SUZUKI Nao
  • 依托单位:
Establishment of molecular targeting therapy against ovarian cancer using human monoclonal antibody
海外基金